Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Erythropoietin reduces white matter damage in two-day-old rats exposed to hypoxic/ischemia injury.
Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
Electroencephalography-Derived Sensory and Motor Network Topology in Multiple Sclerosis Fatigue.
The relevance of cortical lesions in patients with multiple sclerosis.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Yes.
Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy.
Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis.
Multiple sclerosis: Dehydration might contribute to fatigue in MS.
HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.
Demyelinating strain of mouse hepatitis virus infection bridging innate and adaptive immune response in the induction of demyelination.
The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.
Levels and Rates of Physical Activity in Older Adults with Multiple Sclerosis.
Peculiarities of Neurological Disorders and Study Designs.
Behavioral and electromyographic assessment of oxaliplatin-induced motor dysfunctions: evidence for a therapeutic effect of allopregnanolone.
The relationship between sleep quality and perceived fatigue measured using the Neurological Fatigue Index in people with Multiple Sclerosis.
Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis.
Neurodegeneration in multiple sclerosis and neuromyelitis optica.
Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis.
Refined clinical scoring in comparative EAE studies does not enhance the chance to observe statistically significant differences.
Pathophysiological significance of the two-pore domain K(+) channel K2P5.1 in splenic CD4(+)CD25(-) T cell subset from a chemically-induced murine inflammatory bowel disease model.
Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic Neuritis.
Effect of teriflunomide on QuantiFERON-TB Gold results.
Transcutaneous electrical nerve stimulation for spasticity: A systematic review.
Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies.
Variable Density Magnetization Transfer (vdMT) imaging for 7 T MR Imaging.
Pages
« first
‹ previous
…
729
730
731
732
733
734
735
736
737
…
next ›
last »